{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:20:39Z","timestamp":1791411639988,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.brachy.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T18:49:40Z","timestamp":1513882180000},"page":"432-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications"],"prefix":"10.1016","volume":"17","author":[{"given":"Monica M.","family":"Pagliara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Azario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lenkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela G.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4637-6487","authenticated-orcid":false,"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7393-7644","authenticated-orcid":false,"given":"Maria A.","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.11.004_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2005.01.022","article-title":"Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma","volume":"63","author":"Jensen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.004_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/ICU.0b013e328329b62d","article-title":"Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma","volume":"20","author":"Wen","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archopht.117.5.609","article-title":"Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma","volume":"117","author":"Gunduz","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib4","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0161-6420(92)31832-9","article-title":"Radiation maculopathy after proton beam irradiation for choroidal melanoma","volume":"99","author":"Guyer","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2017.11.004_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1259\/bjr\/76813976","article-title":"Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (<or=5 mm) choroidal melanoma lesions","volume":"81","author":"Wilkinson","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2017.11.004_bib6","article-title":"SPIDER: Managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system","volume":"5","author":"Valentini","year":"2008","journal-title":"Ital J Public Health"},{"key":"10.1016\/j.brachy.2017.11.004_bib7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5114\/jcb.2016.61958","article-title":"ENT COBRA (Consortium for Brachytherapy Data Analysis): Interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy)","volume":"8","author":"Tagliaferri","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.11.004_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5114\/jcb.2017.68761","article-title":"INTERACTS (INTErventional Radiotherapy Active Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures","volume":"9","author":"Tagliaferri","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.11.004_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I-125 brachytherapy for choroidal melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.brachy.2017.11.004_bib10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bjo.80.8.732","article-title":"Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma","volume":"80","author":"Summanem","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5114\/jcb.2016.57818","article-title":"Ruthenium-106 brachytherapy for thick uveal melanoma: Reappraisal of apex and base dose radiation and dose rate","volume":"8","author":"Naseripour","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2017.11.004_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.prro.2014.09.005","article-title":"A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma","volume":"5","author":"Takiar","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2017.11.004_bib13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.brachy.2015.04.010","article-title":"Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling","volume":"14","author":"Browne","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.11.004_bib14","first-page":"1919","article-title":"Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: A monoinstitutional experience","volume":"16","author":"Perri","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.brachy.2017.11.004_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1442-9071.2005.01067.x","article-title":"New Zealand experience of I125 brachytherapy for choroidal melanoma","volume":"33","author":"Stack","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0161-6420(82)34611-4","article-title":"Radiation retinopathy","volume":"89","author":"Brown","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2017.11.004_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2014.01.026","article-title":"Uveal melanoma treated with iodine-125 episcleral plaque: An analysis of dose on disease control and visual outcomes","volume":"89","author":"Perez","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.004_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.118.6.773","article-title":"A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma","volume":"118","author":"Gragoudas","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib19","doi-asserted-by":"crossref","first-page":"517032","DOI":"10.1155\/2013\/517032","article-title":"Long-term followup comparing two treatment dosing strategies of (125) I plaque radiotherapy in the management of small\/medium posterior uveal melanoma","volume":"2013","author":"Murray","year":"2013","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib20","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1097\/IAE.0000000000001048","article-title":"Brachytherapy alone or with neoadjuvant photodynamic therapy for amelanotic choroidal melanoma: Functional outcomes and local tumor control","volume":"36","author":"Blasi","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.brachy.2017.11.004_bib21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00417-012-1962-3","article-title":"Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma","volume":"250","author":"Russo","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib22","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ijrobp.2012.01.084","article-title":"Dosimetric benefit of a new ophthalmic radiation plaque","volume":"84","author":"Marwaha","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.004_bib23","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/bjo.84.9.1068","article-title":"Tumor location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy","volume":"84","author":"Finger","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local treatment failure after globe-conserving therapy for choroidal melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2017.11.004_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117305226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117305226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:13:05Z","timestamp":1761531185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117305226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1538472117305226"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.11.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}